Authors
Pradhan R, Petrovic Z, Sadman Sakib M, Schröder S, Manfred Krüger D, Pena T, Diniz E, Burkhardt S, Schütz AL, Gisa V, Grzadzielewska I, Toischer K, Stein TD, Krzysztof Blusztajn J, Delalle I, Radulovic J, Sananbenesi F, Fischer A
Journal
Advanced Science (Weinheim)
Citation
Adv Sci (Weinh). 2026 Mar 14:e14972.
Abstract
The increasing evidence that non-coding RNAs can become deregulated during pathogenesis is dramatically expanding the space for drug discovery beyond the protein-coding genome. Long noncoding RNAs (lncRNAs) are emerging as key regulators of cellular function, yet most remain uncharacterized. Here, we identify a previously unstudied lncRNA, which we named Neuronal Identity (Neuid), a conserved, brain-enriched transcript expressed in neurons. Neuid is downregulated in the brains of Alzheimer’s disease (AD) patients. Mechanistically, Neuid maintains neuronal identity by repressing developmental and glial genes via interaction with the PRC2 subunit EZH2 and regulation of H3K27me3. Knockdown of Neuid disrupts this repression, leading to impaired neuronal activity and memory formation. Importantly, CRISPRa-mediated Neuid overexpression restores neuronal function in Aβ42-treated neurons. These findings identify NeuID as a critical regulator of neuronal plasticity and position it as a promising therapeutic target for AD.
